See more : Aquila Resources Inc. (AQA.TO) Income Statement Analysis – Financial Results
Complete financial analysis of Aesthetic Medical International Holdings Group Limited (AIH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aesthetic Medical International Holdings Group Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Hugo Boss AG (BOSSY) Income Statement Analysis – Financial Results
- Empire Petroleum Corporation (EP) Income Statement Analysis – Financial Results
- Aveer Foods Limited (AVEER.BO) Income Statement Analysis – Financial Results
- Balrampur Chini Mills Limited (BALRAMCHIN.NS) Income Statement Analysis – Financial Results
- First Acceptance Corporation (FACO) Income Statement Analysis – Financial Results
Aesthetic Medical International Holdings Group Limited (AIH)
About Aesthetic Medical International Holdings Group Limited
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 15 treatment centers in China, Hong Kong, and Singapore. Aesthetic Medical International Holdings Group Limited was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 682.59M | 670.09M | 645.59M | 901.57M | 869.05M | 761.31M | 697.40M | 584.86M |
Cost of Revenue | 360.54M | 314.51M | 376.09M | 356.80M | 275.95M | 258.57M | 234.52M | 217.34M |
Gross Profit | 322.05M | 355.59M | 269.50M | 544.78M | 593.10M | 502.74M | 462.87M | 367.52M |
Gross Profit Ratio | 47.18% | 53.07% | 41.74% | 60.43% | 68.25% | 66.04% | 66.37% | 62.84% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 138.61M | 150.38M | 206.97M | 230.65M | 196.33M | 115.49M | 92.84M | 121.76M |
Selling & Marketing | 232.25M | 226.47M | 404.68M | 510.61M | 413.07M | 333.53M | 300.36M | 231.23M |
SG&A | 370.86M | 376.85M | 611.65M | 741.25M | 609.40M | 449.01M | 393.20M | 352.99M |
Other Expenses | 8.30M | -51.43M | 1.83M | -999.00K | 195.41M | -280.21M | -115.72M | 50.73M |
Operating Expenses | 370.86M | 376.85M | 611.65M | 741.25M | 609.40M | 449.01M | 393.20M | 352.99M |
Cost & Expenses | 731.40M | 691.36M | 987.75M | 1.10B | 885.35M | 707.58M | 627.72M | 570.33M |
Interest Income | 78.00K | 155.00K | 113.00K | 1.19M | 388.00K | 322.00K | 868.00K | 309.00K |
Interest Expense | 14.47M | 21.64M | 27.23M | 29.19M | 23.91M | 9.24M | 6.58M | 2.92M |
Depreciation & Amortization | 65.90M | 61.49M | 99.14M | 106.41M | 83.83M | 32.14M | 29.11M | 38.73M |
EBITDA | 25.47M | 9.67M | -240.99M | -90.93M | 177.37M | -192.29M | -17.48M | 91.91M |
EBITDA Ratio | 3.73% | -1.65% | -37.33% | -21.89% | 20.41% | -25.26% | -2.51% | 18.11% |
Operating Income | -48.81M | -72.54M | -340.13M | -303.74M | 93.54M | -227.49M | -50.83M | 66.98M |
Operating Income Ratio | -7.15% | -10.83% | -52.68% | -33.69% | 10.76% | -29.88% | -7.29% | 11.45% |
Total Other Income/Expenses | -6.25M | -72.91M | -339.16M | -63.02M | 168.66M | -287.70M | -122.85M | 10.51M |
Income Before Tax | -55.06M | -94.17M | -681.31M | -259.49M | 152.36M | -233.97M | -53.17M | 64.24M |
Income Before Tax Ratio | -8.07% | -14.05% | -105.53% | -28.78% | 17.53% | -30.73% | -7.62% | 10.98% |
Income Tax Expense | -15.14M | -18.07M | -11.80M | -12.59M | 14.04M | 18.51M | 19.26M | 13.71M |
Net Income | -37.43M | -76.11M | -669.52M | -246.91M | 136.31M | -255.24M | -76.68M | 50.35M |
Net Income Ratio | -5.48% | -11.36% | -103.71% | -27.39% | 15.68% | -33.53% | -10.99% | 8.61% |
EPS | -0.85 | -2.79 | -30.45 | -11.36 | 5.77 | -4.45 | -1.34 | 0.89 |
EPS Diluted | -0.85 | -2.79 | -30.45 | -11.36 | 5.77 | -4.45 | -1.34 | 0.89 |
Weighted Avg Shares Out | 43.89M | 27.30M | 21.99M | 21.74M | 23.61M | 57.40M | 57.40M | 56.66M |
Weighted Avg Shares Out (Dil) | 43.89M | 27.30M | 21.99M | 21.74M | 23.61M | 57.40M | 57.40M | 56.66M |
Marimaca Copper Announces the Appointment of Kieran Daly to its Board of Directors
Marimaca Copper Announces C$68 Million Strategic Investment by Assore International Holdings (AIH) Including Private Placements Totaling C$30.3 Million led by AIH
Aesthetic Medical International Holdings Group Ltd. Announces the Commencement of OTCQX Trading
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing
Aesthetic Medical International to Announce FY2023 Annual Report on April 25, 2024
Why Is Aesthetic Medical (AIH) Stock Up 44% Today?
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of a Letter of Expected Delisting Determination From Nasdaq Staff and Intention to Request a Hearing before the Nasdaq Hearings Panel
Aesthetic Medical International Announces Change of Auditor and Change of Director
Aesthetic Medical International Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
Source: https://incomestatements.info
Category: Stock Reports